CLOV CLOVER HEALTH INVESTMENTS, CORP. /DE
Hospital & Medical Service Plans · Nasdaq · SEC CIK 1801170 · Fiscal year ends 12/31
Financial factors as of 2026-09-30 (2026Q3), TTM = sum of the last four quarters
Growth
TTM revenue YoY54.5%
TTM net income YoY121.3%
TTM EPS YoY119.6%
Revenue 3-yr CAGR14.0%
Net income 3-yr CAGR—
Margins
Gross margin—
Operating margin0.5%
Net margin0.5%
FCF margin4.8%
EBITDA margin0.5%
Returns
ROE3.4%
ROA1.9%
ROIC (approx.)7.2%
Asset turnover4.17x
Leverage & solvency
Liabilities / assets48.1%
Debt / equity0.00x
Current ratio1.55x
Interest coverage—
Cash quality & payout
Operating cash flow / net income10.87x
Accruals ratio-18.7%
Payout ratio—
Capex / revenue0.1%
Factor history charts and full statement history on Pro 🔒
Financial statements
| Line item | FY20252025-12-31 | FY20242024-12-31 | FY20232023-12-31 | FY20222022-12-31 | FY20212021-12-31 |
|---|---|---|---|---|---|
| Income statement | |||||
| Revenue | $1.92B | $1.37B | $1.26B | $1.10B | $1.47B |
| Gross profit | — | — | $257.33M | $22.73M | -$79.18M |
| SG&A expense | $214.27M | $176.48M | $183.09M | $203.68M | $185.29M |
| Operating income | -$85.53M | -$45.75M | -$205.33M | -$286.66M | -$636.99M |
| Interest expense | $0 | $0 | $7,000 | $1.33M | $3.19M |
| Pretax income | -$85.55M | -$43.01M | -$213.36M | — | — |
| Income tax | $0 | $0 | $0 | $0 | $0 |
| Net income | -$85.55M | -$43.01M | -$213.36M | -$339.57M | -$587.76M |
| EBITDA | -$83.84M | -$44.42M | -$202.82M | -$285.48M | -$635.75M |
| EPS (basic) | — | — | -0.44 | -0.71 | -1.42 |
| EPS (diluted) | — | — | -0.44 | -0.71 | -1.42 |
| Weighted avg. shares (diluted) | 511.97M | 490.02M | 482.18M | 476.24M | 412.92M |
| Banking | |||||
| Deposits | $14.60M | $14.60M | $14.70M | $14.30M | $11.10M |
| Balance sheet | |||||
| Cash & equivalents | $78.30M | $194.54M | $122.86M | $186.21M | $299.97M |
| Short-term investments | $23.13M | $27.00M | $100.70M | $189.50M | $21.13M |
| Current assets | $307.86M | $343.12M | $427.97M | $625.00M | $752.55M |
| PP&E, net | $6.38M | $5.31M | $5.08M | $5.75M | $2.29M |
| Goodwill | — | — | $0 | $11.75M | $1.24M |
| Total assets | $541.01M | $580.74M | $570.67M | $808.62M | $950.80M |
| Current liabilities | $208.82M | $213.52M | $261.12M | $431.51M | $371.90M |
| Short-term debt | — | — | — | — | $0 |
| Long-term debt | — | — | — | $0 | $19.94M |
| Total debt | — | — | — | $0 | $19.94M |
| Total liabilities | $232.31M | $239.60M | $284.28M | $451.73M | $410.76M |
| Shareholders' equity | $308.70M | $341.14M | $286.39M | $356.89M | $535.41M |
| Net debt | — | — | — | -$186.21M | -$280.03M |
| Cash flow statement | |||||
| Operating cash flow | -$66.93M | $34.84M | -$144.66M | -$203.93M | -$282.33M |
| Capital expenditure | $2.04M | $1.56M | $584,000 | $4.47M | $723,000 |
| Free cash flow | -$68.98M | $33.29M | -$145.25M | -$208.39M | -$283.05M |
| Investing cash flow | $4.08M | $565,000 | $140.01M | $95.13M | -$435.45M |
| Financing cash flow | -$53.38M | -$17.36M | -$5.07M | -$4.96M | $925.39M |
| Depreciation & amortization | $1.69M | $1.33M | $2.51M | $1.19M | $1.25M |
| Stock-based compensation | $103.66M | $114.33M | $140.93M | $164.31M | $163.72M |
| Share buybacks | $18.30M | $1.77M | $0 | $0 | $147,000 |
Free plan shows the latest 5 periods; Pro shows all 7 🔒
· Financial companies (banks, insurers, …) usually do not report gross profit or operating income; bank revenue is net revenue (net interest income + noninterest income), smaller than "gross interest income + noninterest income".
· No price-based ratios such as P/E or P/B (the site uses no licensed market data). Blanks are shown as —.
Source: SEC EDGAR XBRL (financial statements filed with the SEC), updated 2026-11-18 06:30.